ArticleCell cycle (Georgetown, Tex.)2022

miR-28-5p inhibits cholangiocarcinoma progression and predicts good prognosis of patients.

Tingsong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.